Celgene Gains Option to Buy Partner Forma Therapeutics via US$600 M Multistage Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 4 (Table of Contents)
Published: 29 Apr-2014
DOI: 10.3833/pdr.v2014.i4.2021 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Celgene has paid US$225 M upfront to expand its relationship with Forma Therapeutics with a multistage drug discovery collaboration covering a broad range of protein target families and therapeutic areas...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS